Skip to main content

Table 5 Toxicity

From: NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

AE nab-P + Gem
Grade 3 hematologic AE no (%)
 Anemia 3 (7.3 %)
 Neutropenia 10 (24.3 %)
 Trombocytopenia 5 (12.1 %)
Grade 3 non hematologic AE no (%)
 Fatigue 6 (14.6 %)
 Peripheral Neuropathy 5 (12.2 %)
 Diarrhea 4 (9.7 %)
 Nausea 2 (4.9 %)